Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Pharm Bull ; 37(1): 152-7, 2014.
Article in English | MEDLINE | ID: mdl-24389489

ABSTRACT

The extract of Siegesbeckia pubescens herb and its chemical constituents were tested for the ability to inhibit lipopolysaccharide (LPS)-induced nitric oxide (NO) production in BV2 microglia. The methanol extract and the 90% MeOH fraction of S. pubescens effectively attenuated lipopolysaccharide-induced nitric oxide production. Several steps of chromatography yielded eight ent-kaurane diterpenes (1-8) and one ent-pimarane diterpene (9) from the 90% MeOH fraction. Among these compounds, compounds 2-9 showed significant inhibitory effect on lipopolysaccharide-induced nitric oxide production in BV2 microglia. Compounds 3 and 9 concentration-dependently decreased the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), supported by quantitative real time polymerase chain reaction (PCR) and Western blot analysis. These results suggest that ent-kaurane and ent-pimarane diterpenes isolated from S. pubescens are expected to be potential candidates against neuroinflammation-related disease.


Subject(s)
Abietanes/therapeutic use , Asteraceae/chemistry , Diterpenes, Kaurane/therapeutic use , Inflammation/drug therapy , Microglia/drug effects , Nitric Oxide/biosynthesis , Phytotherapy , Abietanes/pharmacology , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Cyclooxygenase 2/metabolism , Diterpenes, Kaurane/pharmacology , Inflammation/chemically induced , Inflammation/metabolism , Lipopolysaccharides , Mice , Microglia/metabolism , Nitric Oxide Synthase Type II/metabolism , Plant Extracts/pharmacology , Plant Extracts/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...